Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00541632 · ClinicalTrials.gov registry record

BacLite Rapid MRSA Clinical Performance

A clinical trial, sponsored by Solventum US.

Terminated
Registry status

NCT00541632: Clinical Trial study, sponsored by Solventum US.

NCT00541632 is a clinical trial that was terminated before completion, run by Solventum US. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00541632 was terminated before completion, sponsored by Solventum US.

TERMINATED
Registry status

Study Summary

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Trial Details

FieldValue
Start Date 2007-10
Est. Completion 2008-03
Solventum US

41 total trials

Why NCT00541632 stopped before completion

NCT00541632 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 0 interventions.

NCT00541632 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00541632 about?

NCT00541632 is a clinical study titled "BacLite Rapid MRSA Clinical Performance". The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

What is the current status of trial NCT00541632?

This trial is currently terminated. The study started on 2007-10. Estimated completion is 2008-03.

Who is sponsoring clinical trial NCT00541632?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00541632, the US trial registry maintained by the National Library of Medicine. NCT00541632 (unsized enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.